Together, these findings provide direct experimental evidence that AMIGO2 functions as an active driver of EMT-associated migration and invasion in pancreatic cancer cells, thereby reinforcing its central role in PAAD metastasis. This evidence concerns the gene AMIGO2 and pancreatic adenocarcinoma.